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IFN-induced transmembrane protein 3 (IFITM3) is a restriction factor that blocks cytosolic entry of
numerous viruses that utilize acidic endosomal entry pathways. In humans and mice, IFITM3 limits
influenza-induced morbidity and mortality. Although many IFITM3-sensitive viruses are zoonotic,
whether IFITMs function as antiviral restriction factors in mammalian species other than humans
and mice is unknown. Here, IFITM3 orthologues in the microbat (Myotis myotis) and pig (Sus
scrofa domesticus) were identified using rapid amplification of cDNA ends. Amino acid residues
known to be important for IFITM3 function were conserved in the pig and microbat orthologues.
Ectopically expressed pig and microbat IFITM3 co-localized with transferrin (early endosomes)
and CD63 (late endosomes/multivesicular bodies). Pig and microbat IFITM3 restricted cell entry
mediated by multiple influenza haemagglutinin subtypes and lyssavirus glycoproteins. Expression
of pig or microbat IFITM3 in A549 cells reduced influenza virus yields and nucleoprotein
expression. Conversely, small interfering RNA knockdown of IFITM3 in pig NPTr cells and primary
microbat cells enhanced virus replication, demonstrating that these genes are functional in their
species of origin at endogenous levels. In summary, we showed that IFITMs function as potent
broad-spectrum antiviral effectors in two mammals – pigs and bats – identified as major reservoirs
for emerging viruses.
INTRODUCTION
Restriction factors are germline-encoded proteins that
function in a cell-autonomous manner to suppress virus
replication. The IFN-induced transmembrane (IFITM)
proteins are a family of small IFN-stimulated proteins that
affect diverse cellular processes (reviewed by Siegrist et al.,
2011) and were recently identified as antiviral restriction
factors that inhibit the cell entry of multiple pathogenic
viruses (Brass et al., 2009).
To date, IFITMs have been reported to restrict the
enveloped viruses influenza A, West Nile virus and
dengue virus (family Flaviviridae), severe acute respiratory
syndrome coronavirus, Ebola virus and Marburg virus
(family Filoviridae), vesicular stomatitis virus (VSV) and
lyssaviruses (family Rhabdoviridae), human immunodefi-
ciency virus type 1 and several species of the family
Bunyaviridae, as well as a non-enveloped orthoreovirus
(family Reoviridae) (Anafu et al., 2013; Brass et al., 2009;
Huang et al., 2011; Jia et al., 2012; Lu et al., 2011;
Mudhasani et al., 2013; Smith et al., 2013; Weidner et al.,
2010). The common feature of IFITM-sensitive viruses
appears to be their dependence on acidic endosomal entry
pathways, either for proteolytic cleavage, or for pH- or
protease-dependent activation of viral entry proteins into
their fusogenic form. Accordingly, pseudotyped retro-
viruses expressing heterologous surface envelope proteins
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Material.
Journal of General Virology (2015), 96, 991–1005 DOI 10.1099/vir.0.000058
000058 G 2015 The Authors Printed in Great Britain
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/). 991
Downloaded from www.microbiologyresearch.org by
IP:  195.195.217.51
On: Wed, 06 Apr 2016 14:49:23
recapitulate the IFITM sensitivity of the authentic virus
from which the envelope protein derives, and have been
widely used to study IFITM biology (Brass et al., 2009;
Feeley et al., 2011; Huang et al., 2011). IFITMs localize to
membranes of late endosomes and lysosomes and prevent
the release of viral particles from these compartments into
the cytosol (Feeley et al., 2011).
The human IFITM gene family comprises IFITM1, -2, -3
and -5, all of which possess antiviral activity and cluster
together on chromosome 11, as well as IFITM10 whose
function remains unknown. Mice possess orthologues of all
the human IFITM genes and two additional genes, Ifitm6
and -7. IFITM1, -2 and -3 are expressed in a wide range of
tissues (Bailey et al., 2012; Everitt et al., 2013; Siegrist et al.,
2011) whereas IFITM5 expression is limited to osteoblasts
(Moffatt et al., 2008). Of all the IFITMs, IFITM3 is the
most potent anti-influenza effector in vitro (Huang et al.,
2011). Ifitm3 has a critical role in limiting influenza-
induced morbidity and mortality in mice (Everitt et al.,
2012). As the phenotype of influenza-infected Ifitm32/2
mice is indistinguishable from that of mice deleted for the
entire locus (comprising Ifitm1, -2, -3, -5 and -6), Ifitm3
apparently dominates influenza resistance in vivo (Bailey
et al., 2012). Moreover, the importance of IFITM3 was
highlighted by reports showing that an IFITM3 allele
(rs12252-C) is associated with enhanced disease severity
caused by pandemic influenza virus H1N1/09 (Everitt et al.,
2012; Zhang et al., 2013b) and highly pathogenic influenza
virus H7N9 (Wang et al., 2014) and is more frequent in
Chinese than in Caucasian populations.
IFITM proteins comprise a relatively long hydrophilic N-
terminal region, two hydrophobic intramembrane domains
(IM1 and IM2) separated by a conserved intracellular loop
(CIL), and a comparatively short hydrophilic C-terminal
region. IM1 and CIL together constitute the CD225
domain, a functionally poorly defined domain shared by
.300 members of the CD225/pfam04505 protein super-
family. Several alternative topologies have been proposed
for the IFITMs (Chen et al., 1984; Li et al., 2013; Takahashi
et al., 1990; Yount et al., 2012), but the most recent study
suggests that murine Ifitm3 is a type II transmembrane
protein, comprising an intracellular N terminus, an
extracellular C terminus and a membrane-spanning ‘IM2’
domain (Bailey et al., 2013). IFITM function is regulated by
several post-translational modifications. S-Palmitoylation of
IFITM3 on three membrane-proximal cysteine residues
enhances membrane affinity and antiviral activity against
influenza (Yount et al., 2010, 2012). Conversely, lysine-linked
ubiquitination decreases the co-localization of IFITM3 with
endolysosomes and its antiviral potency (Yount et al., 2012).
The Y20 residue, which can be phosphorylated by the
tyrosine kinase Fyn, is critical for targeting IFITM3 to
endolysosomes and for restriction of endosome-dependent
viruses (Jia et al., 2012; John et al., 2013).
Current evidence indicates that IFITMs block viral entry to
the cytosol by preventing fusion between viral and host-cell
membranes. IFITMs multimerize via their IM1 regions
(John et al., 2013) and increase membrane rigidity (Li et al.,
2013). This suggests a model in which IFITMs either
physically resist the deformation of the membrane by the
viral fusion machinery or hinder the lateral mobility of
viral or cellular proteins within the membrane and thereby
block successful pore formation (John et al., 2013; Li et al.,
2013; Perreira et al., 2013). Amini-Bavil-Olyaee et al.
(2013) recently reported that IFITM3 interacts with a
protein involved with cholesterol homeostasis, vesicle-
membrane-protein-associated protein A (VAPA), and
thereby causes cholesterol accumulation in multivesicular
bodies and late endosomes, which inhibits the fusion
between virion and endosomal membranes. However, a
unifying mechanism to explain antiviral restriction by
IFITM proteins remains elusive (Perreira et al., 2013; Smith
et al., 2014). Indeed, recent reports showing that IFITM3
can be co-opted to promote cell entry of human
coronavirus OC43 (Zhao et al., 2014) and human
papillomavirus (Warren et al., 2014) suggest virus-specific
IFITM interactions.
Although the IFITM gene family is evolutionarily con-
served in vertebrates (Hickford et al., 2012; Zhang et al.,
2012), it is unclear whether antiviral activity is also
conserved among vertebrate IFITMs. Here, we focused on
the bat and pig, as these hosts are particularly relevant to
the ecology of several IFITM-sensitive zoonotic viruses.
RESULTS
Sequence analysis of IFITM3 orthologues cloned
from microbat and pig cells
In vertebrates, the IFITM1, -2, -3 and -5 genes cluster
together in an IFITM locus flanked by the B4GALNT4 and
ATHL1 genes. It was not possible to assign pig and bat
IFITM3 orthologues based on conserved synteny due to the
lack of a B4GALNT4 orthologue in pigs, gaps in the
genome assemblies and the low sequencing coverage of the
bat genomes (2.66 for Pteropus vampyrus and 1.76 for
Myotis lucifugus at the time of analysis). Therefore, to
identify IFITM genes, rapid amplification of cDNA ends
(RACE) was performed on a newborn pig tracheal cell line
(NPTr) and primary lung fibroblasts from the greater
mouse-eared bat, Myotis myotis, a European species of
microbat (Vespertilionidae). M. myotis was selected as it is
a known reservoir host for several highly pathogenic
viruses (Amengual et al., 2007; Drexler et al., 2011, 2012)
and genomes are available for other species from the same
genus (Seim et al., 2013; Zhang et al., 2013a).
RACE using primers designed to the conserved central
regions of compiled IFITM-like sequences yielded several
IFITM gene variants, of which the designated IFITM3-
like sequences were the most abundant. For the pig,
the IFITM3-like sequence was the only IFITM variant
identified that had an N-terminal extension typical of
C. T. O. Benfield and others
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IFITM2/3 proteins (compare human IFITM1-3 in Fig. 1b).
For the microbat, the sequence we assigned as IFITM3 was
the most frequent of several long IFITM variants (68% of
sequenced clones) and the only one encoding a double
phenylalanine motif (F8/F9) conserved in the human and
pig IFITM3 orthologues but absent from human IFITM2
(Fig. 1b).
Full-length IFITM3 cDNA sequences were obtained by
reverse transcription-PCR, and introns were identified by
PCR using genomic DNA, thereby confirming that these
were not intronless expressed pseudogenes. The transcript
structure for pig and microbat IFITM3 was the same as for
other experimentally verified IFITM3 orthologues, com-
prising two exons, a single intron of similar size to other
IFITM3 genes and a conserved exon–exon junction site
(Fig. 1a). BLAST searches revealed that the IFITM3 sequence
from NPTr cells was identical to the Sus scrofa IFITM3
reference sequence (GenBank accession no. NM_001201382.1),
and the closest match for the cloned microbat IFITM3 was a
‘predicted IFITM3-like’ gene from M. lucifugus (GenBank
accession no. XP_006108229.1, 95% amino acid identity).
Multiple sequence alignments showed that amino acid
residues that are functionally important in murine and
human IFITM3 were conserved in the cloned pig and
microbat orthologues (Fig. 1b). These included: (i) three
cysteine residues that are S-palmitoylated (Yount et al.,
2010); (ii) several lysine residues modified by ubiquitin-
ation (Yount et al., 2012) (including K88, which can be
monomethylated; Shan et al., 2013); (iii) the Y20 residue
critical for endosomal targeting (Jia et al., 2012; John et al.,
2013); (iv) two phenylalanine residues (F75 and F78),
which mediate oligomerization (John et al., 2013); and (v)
R85, R87 and Y99 shown to influence antiviral restriction
(John et al., 2013) (Fig. 1b, shaded residues). The microbat
and pig IFITM3 proteins were most divergent from human
IFITM3 at their N and C termini, and were most conserved
in the central CD225 domain, a pattern shared with other
orthologues (chicken and mouse Ifitm3) and paralogues
(human IFITM2 and IFITM1) (Fig. 1b).
Microbat and pig IFITM3 localize to transferrin-
and CD63-positive endosomes
To analyse the IFITM3 proteins, A549 cells (which express
low levels of endogenous IFITM3; Brass et al., 2009) were
stably transduced to express C-terminally haemagglutinin
(HA)-tagged IFITM3 from pig, microbat or human. Prior
work has shown that C-terminal epitope tags do not affect
the function or expression levels of IFITM3, and indicate
that tagged constructs adopt the same topology as the WT
protein (Bailey et al., 2013).
Similar to human IFITM3, both pig and microbat IFITM3
had a punctate intracellular distribution following cell
fixation and permeabilization (Fig. 2) and co-localized with
endocytosed transferrin (early endosomes) and with CD63,
a marker for late endosomes/multivesicular bodies (MVBs),
but not with the lysosomal marker LAMP1 (Fig. 2). There
was an enlargement of CD63-positive structures in cells
expressing microbat or human IFITM3 in comparison with
the smaller CD63-positive vesicles seen in pig IFITM3-
expressing or untransduced A549 cells (Fig. 2b). Enlargement
of CD63-containing compartments was most marked in cells
containing larger foci of IFITM3–HA staining. Microbat
IFITM3–HA sometimes co-localized with CD63 in ‘hollow’
ring-like structures (arrows in Fig. 2b).
Endocytic uptake of microbat and pig IFITM3 from
the plasma membrane
To investigate the trafficking of pig and microbat IFITM3
proteins, live cells were incubated with FITC-conjugated
anti-HA antibody and Alexa Fluor 546-conjugated trans-
ferrin prior to fixation. When labelling was performed on
ice, endocytosis was prevented, as indicated by the weak
stippled transferrin signal, probably corresponding to
clathrin-coated pits pre-internalization (Fig. 3a). Under
these conditions, IFITM3 from the three species was
detected on the plasma membrane, clearly highlighting
filopodia and membrane ruffles, whilst no vesicular
staining was observed. In contrast, when labelling was
performed at 37 uC to allow endocytosis, anti-HA staining
showed that pig, microbat and human IFITM3 formed
discrete puncta, which, as observed previously, overlapped
or were closely associated with transferrin-positive endo-
somes (Fig. 3b). For all IFITM3 proteins, internalization of
the anti-HA antibody by live cells identified larger, brighter
puncta that were more widely distributed within the
cytosol compared with the HA staining seen previously
following fixation and permeabilization (indicating that
permeabilization may cause some extraction of the
membrane-associated IFITM3). In conclusion, pig and
microbat IFITM3 share the following with their human
counterpart: (i) plasma membrane trafficking; (ii) extra-
cellular exposure of their C termini (allowing detection of
the C-terminal HA tag in intact cells); and (iii) endocytic
uptake from the plasma membrane into the endosomal
pathway.
Microbat and pig IFITM3 restrict cell entry
mediated by influenza HA
To determine whether pig and microbat IFITM3 restrict
influenza A virus entry, lentiviruses expressing the HA
proteins from diverse influenza subtypes were used to
infect A549 cells that were untransduced or had been
transduced to express either human IFITM3, pig IFITM3
(Fig. 4a) or microbat IFITM3 (Fig. 4b). Three independ-
ently cloned cell lines of the pig and microbat IFITM3
proteins markedly inhibited the infectivity of all influenza
HA subtypes tested, including both group 1 and group 2
HAs and highly pathogenic avian H5 and H7 (Fig. 4). Pig
or microbat IFITM3 did not restrict viruses pseudotyped
with the entry proteins of the gammaretroviruses ampho-
trophic murine leukemia virus or Gibbon ape leukemia
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virus (Fig. S1, available in the online Supplementary
Material), consistent with previous studies on human
IFITM3 (Brass et al., 2009; Huang et al., 2011).
Microbat and pig IFITM3 inhibit
replication-competent influenza virus
To assess the effect of the IFITM3 orthologues on replication-
competent influenza virus, untransduced A549 cells or cells
expressing either human, pig or microbat IFITM3 were
infected with influenza A/WSN/33 (H1N1) and nucleopro-
tein (NP) expression was quantified using flow cytometry.
Expression of either pig or microbat IFITM3 led to a marked
reduction in the proportion of NP-positive cells for all cell
clones (Fig. 5a). There was a slight variation in the degree of
restriction between the three cell lines expressing pig IFITM3
(Figs 5a and Fig. S2) despite comparable expression of
IFITM3–HA seen by Western blotting (Fig. S2).
Stable expression of pig, microbat or human IFITM3 in
A549 cells significantly reduced single-cycle growth of
influenza A/WSN/33 (Fig. 5c), consistent with reduced NP
expression measured in parallel (Fig. 5b). Inhibition of
virus yields was more profound following a low m.o.i.
infection (.1 log10 for pig IFITM3 and .2 log10 for both
microbat and human IFITM3) relative to control green
fluorescent protein (GFP)-expressing cells (Fig. 5d). A
similar pattern of restriction was also observed when NP
expression was analysed after infections with an avian-like
swine influenza strain, A/swine/453/06 (H1N1) (Fig. 5b).
Levels of the stably expressed proteins were examined by
Western blotting against the C-terminal HA epitope tag,
and showed that pig IFITM3, human IFITM3 and GFP
expression were comparable, whilst microbat IFITM3 was
more highly expressed (Figs 5b and S3).
Microbat and pig IFITM3 block cell entry mediated
by lyssavirus entry proteins
In light of data that suggest there may be virus-specific
antiviral determinants of IFITM (John et al., 2013; Zhao
et al., 2014), it was of interest to explore the antiviral
spectrum of pig and microbat IFITM3, especially for
viruses that naturally infect these species.
A549 cells stably expressing either pig, microbat or human
IFITM3 were infected with pseudotyped lentiviruses
that expressed the envelope glycoproteins from isolates
representing different lyssavirus phylogroups, namely
rabies virus strain Evelyn Rokitniki Abelseth (phylogroup
1), Mokola virus (phylogroup 2), Lagos bat virus
(phylogroup 2) and West Caucasian bat virus (phylogroup
3). Expression of IFITM3 from microbat, pig or human
reduced infectivity mediated by all four lyssavirus entry
proteins, in all cases by approximately 2 log10 relative to the
control cells (Fig. 6). Thus, the pig and microbat IFITM3
orthologues inhibit cell entry mediated by multiple
lyssavirus glycoproteins (G proteins).
IFITM3 activity in pig and microbat cells
Finally, we addressed the contribution of IFITM3 to
antiviral responses in pig and microbat cells. Endogenous
IFITM3 expression was measured using TaqMan quanti-
tative reverse-transcription PCR (qRT-PCR) designed to
specifically detect IFITM3 mRNA and not other IFITM
paralogues identified in these cells by RACE. Baseline levels
of IFITM3 mRNA were readily detected in both the porcine
NPTr cells [threshold cycle (Ct) value of IFITM3522.7;
Ct value of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH)521.33] and in microbat lung fibroblasts (Ct
value of IFITM3525.8; Ct value of GAPDH522.8). IFITM3
induction was assessed in response to the dsRNA analogue
poly(I : C), a molecular pattern associated with viral infec-
tion, which is recognized by Toll-like receptor 3 and induces
type I IFN in porcine (Provost et al., 2012) and bat (Biesold
et al., 2011; Omatsu et al., 2008; Zhou et al., 2011) cells.
Poly(I : C) addition led to a 3.5-fold increase in pig IFITM3
and a twofold increase in microbat IFITM3 mRNA levels
(Fig. 7). The microbat cells were also stimulated via
poly(I : C) transfection; as in pteropid bat lung cells (but
not primary cells from other tissues) this enhanced IFN-b
induction relative to extracellular delivery of poly(I : C)
(Zhou et al., 2011). However, transfection of poly(I : C) into
microbat cells resulted in a similar degree of IFITM3
induction (2.3-fold) (Fig. 7).
Next, the function of endogenous IFITM3 was assessed
using small interfering RNA (siRNA) designed using the
RACE sequence data to target IFITM3 and not other
putative IFITM paralogues. siRNA targeting IFITM3 or
control non-targeting siRNAs were transfected into cells
with poly(I : C) induction of IFITM3. IFITM3 mRNA was
quantified by qRT-PCR and the biological effect of the
knockdown assessed by infection with influenza A/WSN/33
(Fig. 8). Transfection of siRNA against pig IFITM3 led to
a 63% knockdown in IFITM3 mRNA (fold change of
Fig. 1. Multiple sequence alignments with microbat and pig IFITM3. (a) Pig and microbat IFITM3 nucleotide sequences were
aligned with experimentally verified IFITM3 orthologues. The intron–exon boundary is shown (exon1: black; exon 2: blue) and
intronic sequences flanking the splice sites are in red lower-case letters. An asterisk indicates identical nucleotides. (b) Pig and
microbat IFITM3 amino acid sequences were aligned with other IFITM proteins. Text colour of amino acid residues denotes their
physiochemical properties: blue: acidic, red: small and hydrophobic, magenta: basic, green: hydroxyl, sulfhydryl, amine and
glycine. An asterisk indicates identical amino acid residues, ‘:’ indicates residues with strongly similar properties and ‘.’ indicates
residues with weakly similar properties. The arrow indicates the exon–exon boundary. The protein domains of human IFITM3 are
shown (according to John et al., 2013): IM1, CIL and IM2. Highlighted residues are discussed within the text.
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Fig. 2. Subcellular localization of IFITM3
proteins. A549 cells stably expressing HA-
tagged IFITM3 proteins from human, pig or
microbat (or untransduced cells) were fixed,
permeabilized and stained for HA, CD63 (b) or
LAMP1 (c). In (a) cells were incubated with
Alexa Fluor 546-conjugated transferrin before
fixation and staining with FITC-conjugated
anti-HA. Nuclei were stained with DAPI and
the coverslips examined by confocal micros-
copy. Images show representative staining
patterns, and merged images are also shown.
The right-hand column shows phase-contrast
images. Bar, 10 mm. Arrows in (b) identify
‘ring-like’ staining of microbat IFITM3–HA and
CD63.
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1.4 log2) (Fig. 8a), a 3.4-fold increase in virus yield (Fig.
8b) and a twofold increase in the proportion of influenza
NP-positive cells (Fig. 8c) relative to control siRNA-
transfected cells. In the absence of poly(I : C) stimulation,
IFITM3 knockdown in NPTr cells increased influenza NP-
positive cells more (3.3-fold) (Fig. 8d), suggesting that
additional poly(I : C)-induced genes complement IFITM3-
mediated influenza virus restriction. Microbat IFITM3
knockdown in the absence of poly(I : C) stimulation (Fig.
8e–g) reduced IFITM3 mRNA levels by 60% (fold change
of 1.3 log2) (Fig. 8e) and led to a twofold increase in
infectious yields (Fig. 8f) and a threefold increase in NP
expression (Fig. 8g), relative to control siRNA transfection.
Thus, endogenous IFITM3 in pig tracheal NPTr cells and
microbat lung cells restricts influenza virus. Lastly, following
siRNA knockdown of baseline IFITM3 in a microbat cell
line, overexpression of microbat IFITM3 significantly inhib-
ited influenza NP expression (Fig. S4).
DISCUSSION
Species differences in restriction factors can determine
differential viral susceptibility (Duggal & Emerman, 2012;
Fadel & Poeschla, 2011; Kirmaier et al., 2010; McNatt et al.,
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Fig. 3. Endocytic uptake of IFITM3 proteins.
Live A549 cells expressing HA-tagged IFITM3
from human, pig or microbat (or untransduced
cells) were incubated either on ice (a) or at
37 6C (b) with FITC-conjugated anti-HA and
Alexa Fluor 546-conjugated transferrin. After
cell fixation, nuclei were stained with DAPI and
the coverslips examined by confocal micros-
copy. The two right-hand columns showed
merged images and phase-contrast images.
Bar, 10 mm.
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2009). However, antiviral immunity in reservoir and spill-
over hosts remains poorly understood, although important
for understanding viral emergence (Bean et al., 2013). Here,
we showed that IFITM3 proteins with broad-spectrum
antiviral function are conserved in swine and a member of
the order Chiroptera, hosts of numerous zoonotic viruses.
The RACE reactions used here captured multiple possible
expressed IFITM paralogues by using primers against the
conserved CD225 domain. We assigned microbat IFITM3
using several criteria. First, it encoded a double phenyl-
alanine motif (F8/F9) found only in other IFITM3
orthologues (whereas the other microbat IFITM variants
resembled human IFITM2 in having a single phenylalanine
at this position). Secondly, the microbat IFITM3 had an
intracellular location and co-localized with endosomal
markers. Conserved genome synteny was used previously
to help assign IFITM genes (Smith et al., 2013; Zhang et al.,
2012), but was of limited use in the case of the poorly
assembled IFITM loci in the pig and microbat genomes.
Moreover, the IFITM gene family is associated with
numerous processed pseudogenes, gene duplications and
copy-number variation (Siegrist et al., 2011; Zhang et al.,
2012), which significantly complicate the assignment of
gene orthology. Although a recent computational study
identified eight pig IFITM family members with expressed
sequence tag evidence (Miller et al., 2014), it lacked the
functional validation presented here.
Functionally important amino acid residues for human or
mouse IFITM3 were conserved in pig and microbat
IFITM3, indicating that these may be functionally import-
ant sites across the orthologues. Amino acid residues are
less conserved within IM2 compared with IM1, although
IM2 can function as a signal anchor for membrane
localization (Bailey et al., 2013) and is also sufficient to
mediate the IFITM3–VAPA interaction (Amini-Bavil-
Olyaee et al., 2013).
We showed here that C-terminally HA-tagged IFITM3 (of
human, pig and microbat) was clearly detectable at the
plasma membrane after live cell staining. These data
support recent evidence for a luminal (i.e. extracellular)
exposure of the C terminus (Bailey et al., 2013), and
indicate that pig and microbat IFITM3 adopt a similar
topology. Other studies have also reported that a
proportion of human IFITM3 localizes to the plasma
membrane (Amini-Bavil-Olyaee et al., 2013; Bailey et al.,
2013; Brass et al., 2009), and it is thought that the
20YEML23 motif acts as a lysosomal sorting signal for the
internalization of IFITM3 into the endosomal pathway (Jia
et al., 2012; John et al., 2013). Pig and microbat IFITM3
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contain 20YEML23 and 20YEVL23, respectively (which
conform to the consensus sequence for a tyrosine-based
sorting signal YxxW, where W is a residue with a bulky
hydrophobic side chain; Bonifacino & Traub, 2003), and
likewise were observed to traffic into endosomes following
their cell-surface staining. Pig and microbat IFITM3 co-
localized with endocytosed transferrin (early endosomes)
and CD63 (late endosomes/MVBs) as seen for human
IFITM3 (Figs 2 and 3) (Amini-Bavil-Olyaee et al., 2013;
Feeley et al., 2011; Huang et al., 2011; Jia et al., 2012; Lu
et al., 2011). Expression of both microbat and human
IFITM3 caused expansion of CD63-positive endosomal
compartments, consistent with the documented ability of
IFITM3 to induce MVB formation (Amini-Bavil-Olyaee
et al., 2013). Furthermore, in some cells, microbat IFITM3
co-stained with CD63 in ring-like structures, a phenom-
enon reported for human IFITM3 and enhanced by
overexpression of its interaction partner, VAPA (Amini-
Bavil-Olyaee et al., 2013). In our hands, neither human
IFITM3 nor its pig and microbat orthologues co-localized
with the lysosomal marker LAMP1, which is consistent
with some (Yount et al., 2010) but not other (Feeley et al.,
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2011; Huang et al., 2011) reports for IFITM3 localization.
These discrepancies regarding localization may be due to
the multiple post-translational modifications of IFITM3
(Yount et al., 2012) and/or cell type-dependent differences
in its topology (Bailey et al., 2013).
We showed that both pig and microbat IFITM3 restricted
cell entry mediated by multiple influenza A virus HA (a
class I fusion protein) and lyssavirus G (a class III fusion
protein) proteins. Restriction at the level of cell entry
correlated with significant inhibition of influenza virus
yields and NP expression. The microbat, pig and human
IFITM3-expressing A549 cells varied in their IFITM3
expression levels, which may underlie variation seen in
the degree of restriction. However, anti-influenza restric-
tion by pig IFITM3 was in general lower than that seen for
human IFITM3, despite comparable expression levels. We
found that pig and human IFITM3 could restrict avian,
swine and human influenza A subtypes. Similarly, chicken
IFITM3 inhibited viral pseudotypes bearing HAs from both
avian and human strains (Smith et al., 2013). siRNA
knockdown of endogenous pig and microbat IFITM3
enhanced influenza replication by a similar degree to that
seen following knockdown of human IFITM3 (Huang et al.,
2011) or chicken IFITM3 (Smith et al., 2013). IFITM3 was
expressed constitutively in pig and bat cells (as reported for
other IFITM3 orthologues; Bailey et al., 2012; Everitt et al.,
2012, 2013; Friedman et al., 1984; Smith et al., 2013).
Baseline levels of IFITM3 in the pig and bat cells were
sufficient to limit virus replication and, following siRNA
targeting of baseline IFITM3, microbat IFITM3 was also
capable of restricting influenza virus when overexpressed in
microbat cells. As pig IFITM3 was moderately induced by
poly(I : C) and upregulated upon viral challenge in vivo
(Andersson et al., 2011; Miller et al., 2014), pig IFITM3 is
likely to be relevant to host antiviral responses.
Here, we showed that influenza A viruses and lyssaviruses,
virus families that share an ancient co-evolutionary history
with bats (Badrane & Tordo, 2001; Tong et al., 2013), are
restricted by microbat IFITM3. Bats harbour many diverse
virus types and are important reservoirs of zoonotic
infections (Drexler et al., 2014; Quan et al., 2013; Smith
& Wang, 2013; Tong et al., 2013). However, the basis for
the intimate association between bats and viruses remains
enigmatic, particularly the relative importance of immuno-
logical compared with ecological or life history factors
(Kupferschmidt, 2013). Although transcriptional induction
of chiropteran IFN-stimulated gene orthologues has been
reported (Papenfuss et al., 2012; Zhou et al., 2013), there is
a striking lack of functional data for any of these genes. We
demonstrated that bats do encode functional IFITM3 and
therefore are likely to be competent in this aspect of
intrinsic antiviral restriction.
METHODS
Cells. A549 cells were maintained in F12 medium, and 293T, NPTr
(Ferrari et al., 2003) and FLN-R cells (Friedrich-Loeffler-Institut)
were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) with
10% FCS. Primary lung cells from the microbat (M. myotis) were
grown in DMEM containing 10% FCS, penicillin (100 units ml21)
and streptomycin (100 mg ml21) and 20% amnioMAX (Gibco).
RACE and IFITM3 cloning.NPTr and microbat cells were transfected
with poly(I : C) (Invivogen) at 33 mg ml21 using Lipofectamine 2000,
and 4 h later, total RNA and genomic DNA were isolated (Qiagen
AllPrep kit). 59 and 39 IFITM cDNA fragments were generated using a
SMARTer RACE cDNA amplification kit (Clontech) and the following
primers: 5Bat: 59-GCCCAGAGCTATGCGTCCACCGCCAAGTGCC-
39, and 3Bat: 59-CGTCTGGTCCCTGTTCAACACCCTCTTC-39; and
5Pig: 59-GATGTTCAGGCACTTGGCGGTGGAGGCATAGCTC-39,
and 3Pig: 59-TGAACTGGTGCTGCCTGGGCTTCGTGG-39. PCR
products were TA cloned and multiple clones were sequenced using
Sanger sequencing. Non-coding sequences identified by RACE
were used to design primers for PCR amplification of full-length
IFITM3 (BatIFITM3ncrF: 59-GCATCCACACGCCATCTGCTC-39,
and BatIFITM3ncrR: 59-GAACGCCATTGTGCACATGTGC-39; and
PigIFITM3ncrF: 59-ACAGCTTCTCCTGGGCACCATG-39, PigIFITM3ncrR:
59-GTATGTGCTGCTGTGAAAGGAG-39). Pig IFITM3 and microbat
MO
KV
W
CB
V
LB
V
ER
A
0.001
0.01
0.1
1
10
Lyssavirus species
R
el
at
iv
e 
in
fe
ct
iv
ity
GFP
Human IFITM3
Pig IFITM3 
Microbat IFITM3 
Fig. 6. Microbat and pig IFITM3 inhibit cell entry mediated by
lyssavirus G proteins. A549 cells stably expressing GFP, human
IFITM3, pig IFITM3 (clone 1) or microbat IFITM3 (clone 2) were
infected with pseudotyped viruses that expressed the envelope
glycoprotein from Mokola virus (MOKV), West Caucasian bat virus
(WCBV), Lagos bat virus (LBV) or rabies virus strain Evelyn
Rokitniki Abelseth (ERA). At 48 h post-infection, luciferase
reporter activity was measured and normalized to GFP-expressing
cells (relative infectivity of 1 corresponding to 25000–80000
relative light units according to pseudotype used). Results are
shown as means±SD (n53) and data are representative of three
independent experiments.
C. T. O. Benfield and others
1000 Journal of General Virology 96
Downloaded from www.microbiologyresearch.org by
IP:  195.195.217.51
On: Wed, 06 Apr 2016 14:49:23
IFITM3 were synthesized as codon-optimized genes for expression in
human cells (GeneArt) and cloned into the BamHI and NotI sites of
the lentivirus vector pSIN-BNHA (derived from pHRSIN-CSGW;
Demaison et al., 2002).
Creation of IFITM3-expressing cell lines. Lentiviruses expressing
IFITM3 (or GFP as a control) were produced by co-transfecting 293T
cells using Fugene HD with the packaging plasmid p8.91 (Zufferey
et al., 1997) (1 mg), the VSV-G-expressing plasmid pMDG (1 mg) and
the lentivirus vector pSIN-BNHA (1.5 mg) containing either pig
IFITM3, microbat IFITM3 or GFP. Supernatants were harvested at
48 and 72 h, filtered (0.45 mm) and used to transduce A549 cells.
Transduction efficiency was checked after 48 h by flow cytometric
detection of HA. Single-cell clones were generated using limiting dilution
and analysed for HA expression. Those with the most similar expression
levels were selected for experiments. Human IFITM3-expressing A549
cells were generated using the same method (Smith et al., 2013).
Pseudotyped lentivirus cell entry assay. Lentiviral pseudotypes
were produced as described previously (Ferrara et al., 2012; Wright
et al., 2008). For the entry assay, A549 cells were seeded in white 96-
well plates (104 cells per well) 1 day prior to infection with luciferase-
expressing pseudotypes expressing influenza HA (GenBank accession
nos: H1, AAD17229.1; H5, ABP51969.1; H10, ABI84534.1; H14,
BAF43460.1; H7, CAD37074.1; H3, AAA43099.1; H15, AAA96134.1),
the G proteins from Mokola virus (MOKV.98/071 RA361;
GQ500108), Lagos bat virus (LBV.NIG56-RV1; HM623779), West
Caucasian bat virus (AAR03484) or rabies virus Evelyn Rokitniki
Abelseth strain (ABN11294) or amphotrophic murine leukemia virus
(MLV-A) or gibbon ape leukemia virus (GALV) envelope proteins.
The H1 and H3 HAs were human in origin, and the other HA
subtypes were avian in origin. Cells were infected in triplicate, and
48 h later, luciferase activity was measured using a Bright-Glo
Luciferase Assay System (Promega).
siRNA transfection and qRT-PCR. siRNAs against pig IFITM3
(59-GCTCATAAAGGATTACAGA-39) or microbat IFITM3 (59-
CGAGGACGACGGTGGTCAA-39) (ON-TARGETplus; Dharmacon)
were designed using knowledge of other IFITM paralogues and the
Dharmacon siDesign Centre. The ON-TARGETplus non-targeting
siRNA pool and an siRNA targeting GFP were used as controls.
siRNA was transfected into cells (20 pmol per well of a 12-well plate)
using Lipofectamine RNAiMAX. After 48 h, RNA was extracted
(RNeasy kit; Qiagen) and a Quantitect multiplex RT-PCR kit
(Qiagen) was used to measure IFITM3 and GAPDH simultaneously
using TaqMan gene expression assays (Applied Biosystems; primer
sequences available on request). MxPro software was used for
comparative quantification of IFITM3 relative to the GAPDH
reference gene.
Flow cytometry. Cells were infected in triplicate with influenza A/
WSN/33 in medium containing 2% FCS. Cells were trypsinized, fixed
using BD Fixation/Permeabilization solution for 20 min and washed
twice in BD Perm/Wash buffer before incubation with FITC-
conjugated anti-influenza NP IgG (Abcam) for 40 min at 4 uC.
After staining, the cells were washed, resuspended in PBS and
analysed using a Becton Dickinson FACSCalibur and Cell Quest Pro.
For each sample, 10 000 cells (gated by forward and side scatter) were
analysed for FITC fluorescence.
Western blotting. After cell lysis using RIPA buffer, proteins were
separated by SDS-PAGE (4–12% TGX gel; Bio-Rad) and transferred
to nitrocellulose membrane. After blocking (5% Marvel, 0.1% Tween
20 in PBS), the membranes were incubated for 1 h at room
temperature with antibodies against influenza NP, b-actin or the
HA tag (clone HA.C5; all from Abcam). HRP-conjugated secondary
antibodies were used followed by enhanced chemiluminescent
detection.
Virus yield assay. Cells were infected in triplicate with influenza A/
WSN/33 in medium containing 2% FCS. After 1 h infection at 37 uC,
the cells were washed three times in PBS. At the indicated times post-
infection, supernatants were harvested and the virus yields titrated on
MDCK cells by plaque assay (Matrosovich et al., 2006).
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Immunofluorescence. Cells were fixed with 4% paraformaldehyde
(20 min at room temperature). For transferrin co-localization, cells
were pre-incubated with Alexa Fluor 546-conjugated transferrin
(5 mg ml21; Molecular Probes) for 10 min before fixation. Cells were
permeabilized using 0.2% Triton X-100, blocked using antibody
buffer (0.1% Tween 20 and 10% goat serum in PBS) and stained with
FITC-conjugated anti-HA (Bethyl Laboratories), anti-LAMP1 (clone
H4A3; Abcam) or anti-CD63 (Santa Cruz Biotechnology) for 1 h at
room temperature. Dylight 594-conjugated goat anti-mouse IgG was
used to detect the anti-CD63 and anti-LAMP1 antibodies. Live cell
staining was performed at 37 uC or on ice, with solutions equilibrated
accordingly. Cells were washed twice in serum-free medium before
incubation for 30 min with FITC-conjugated anti-HA and Alexa
Fluor 546-conjugated transferrin (in serum-free medium). Cells were
then washed quickly in PBS and fixed immediately using 4%
paraformaldehyde (20 min). Coverslips were mounted using ProLong
Gold reagent with DAPI and examined with a Zeiss LSM 780 confocal
microscope.
Sequence analysis. Multiple sequence alignments were performed
using Clustal Omega (version 1.2.0), and Seaview (Gouy et al., 2010)
was used for manual editing.
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